Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations
Clinical trial NCT06020118 · COMPLETED
Trial details
- NCT number
- NCT06020118
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2024-03-07
- Enrollment
- 455
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.